| HOME >> MEDICINE >> TECHNOLOGY |
Nine out of 10 ENDOMETRIN users would recommend it to a friend
PARSIPPANY, N.J., Sept. 17 /PRNewswire/ -- Results of a nationwide survey of infertility patients undergoing an assisted reproductive technology treatment (ART), such as in vitro fertilization, revealed that patients prefer ENDOMETRIN(R) (progesterone) Vaginal Inserts to progesterone-in-oil (PIO) injections, and to all other vaginal progesterone supplements. The reasons cited most frequently for their preference included easy, convenient and pain-free administration.
Adequate progesterone support is considered extremely important for a successful pregnancy. Since natural progesterone production may be compromised by ART, progesterone supplements are used extensively for luteal phase and early pregnancy support. There are several forms: oral, injection, and vaginal -- tablet inserts, vaginal capsules, suppositories and gels.
"The survey confirms what we hear all the time from patients -- that when they reach the final stage of their IVF treatment, the last thing they want is another series of shots or inconvenient treatments," said Christine Stroup, RN. "Our patients are very pleased with ENDOMETRIN because it's simple to use and very convenient."
"I've tried just about every progesterone treatment available, and was so happy to find one that didn't hurt, like shots, and wasn't messy, like gels and suppositories," said Victoria Knapp, IVF patient. "After all those cycles of treatment I went through, it was a relief to find one that was so simple to use."
The Evaluation of Attitudes and Satisfaction with Endometrin Survey of 212 patients was commissioned by Ferring Pharmaceuticals Inc. to compare patient satisfaction with ENDOMETRIN, the most recent progesterone supplement to enter the market, with all other progesterone supplements.
Key Survey Findings
-- More than 90 percent of patients would recommend ENDOMETRIN to a friend
underg
'/>"/>
| SOURCE Ferring Pharmaceuticals Copyright©2008 PR Newswire. All rights reserved |